Balcar L; Semmler G; Oberkofler H; Zandanell S; Strasser M; Datz L; Niederseer D; Feldman A; Stickel F; Datz C; Paulweber B; Aigner E, 2022. PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary center.  Dig Liver Dis 54(1):84-90

Fessas P; Naeem M; Pinter M; Marron TU; Szafron D; Balcar L; Saeed A; Jun T; Dharmapuri S; Gampa A; Wang Y; Khan U; Muzaffar M; Navaid M; Lee PC; Bulumulle A; Yu B; Paul S; Nimkar N; Bettinger D; Hildebrand H; Abugabal YI; Pressiani T; Personeni N; Nishida N; Kudo M; Kaseb A; Huang YH; Ang C; Pillai A; Rimassa L; Naqash AR; Sharon E; Cortellini A; Pinato DJ, 2021. Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma.  Liver Cancer 10(6):583-592

Pomej K; Balcar L; Scheiner B; Semmler G; Meischl T; Mandorfer M; Reiberger T; Müller C; Trauner M; Pinter M, 2021. Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib.  J Hepatocell Carcinoma 8:1485-1493

Scheiner B; Pomej K; Kirstein MM; Hucke F; Finkelmeier F; Waidmann O; Himmelsbach V; Schulze K; von Felden J; Fründt TW; Stadler M; Heinzl H; Shmanko K; Spahn S; Radu P; Siebenhüner AR; Mertens JC; Rahbari NN; Kütting F; Waldschmidt DT; Ebert MP; Teufel A; De Dosso S; Pinato DJ; Pressiani T; Meischl T; Balcar L; Müller C; Mandorfer M; Reiberger T; Trauner M; Personeni N; Rimassa L; Bitzer M; Trojan J; Weinmann A; Wege H; Dufour JF; Peck-Radosavljevic M; Vogel A; Pinter M, 2021. Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score.  J Hepatol.

Pomej K; Scheiner B; Hartl L; Balcar L; Meischl T; Mandorfer M; Reiberger T; Müller C; Trauner M; Pinter M, 2021. COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospital.  PLoS One 16(8):e0256544

Semmler G; Pomej K; Bauer DJM; Balcar L; Simbrunner B; Binter T; Hartl L; Becker J; Pinter M; Quehenberger P; Trauner M; Mandorfer M; Lisman T; Reiberger T; Scheiner B, 2021. Safety of direct oral anticoagulants in patients with advanced liver disease.  Liver Int 41(9):2159-2170

Balcar L; Semmler G; Pomej K; Simbrunner B; Bauer D; Hartl L; Jachs M; Paternostro R; Bucsics T; Pinter M; Trauner M; Mandorfer M; Reiberger T; Scheiner B, 2021. Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute-on-chronic liver failure.  United European Gastroenterol J 9(4):427-437

Semmler G; Wernly S; Bachmayer S; Leitner I; Wernly B; Egger M; Schwenoha L; Datz L; Balcar L; Semmler M; Stickel F; Niederseer D; Aigner E; Datz C, 2021. Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-Rather a Bystander Than a Driver of Mortality.  J Clin Endocrinol Metab 106(9):2670-2677

Semmler G; Balcar L; Oberkofler H; Zandanell S; Strasser M; Niederseer D; Feldman A; Stickel F; Strnad P; Datz C; Paulweber B; Aigner E, 2021. PNPLA3 and SERPINA1 Variants Are Associated with Severity of Fatty Liver Disease at First Referral to a Tertiary Center.  J Pers Med 11.

Pomej K; Scheiner B; Park D; Bauer D; Balcar L; Meischl T; Mandorfer M; Reiberger T; Müller C; Trauner M; Pinter M, 2020. Vascular Complications in Patients with Hepatocellular Carcinoma Treated with Sorafenib.  Cancers (Basel) 12.

Publication list retrieved from NCBI using ImpactPubs